A groundbreaking and highly controversial sporting event, dubbed the ‘Enhanced Games,’ is set to take place in Las Vegas this Sunday. The competition distinguishes itself from traditional athletics by allowing participants to utilize performance-enhancing drugs, a policy that has drawn sharp criticism from the World Anti-Doping Agency and the International Olympic Committee. Despite the backlash, the event has attracted significant attention, featuring a roster of 42 athletes, including several Olympic medalists such as Fred Kerley, James Magnussen, and Cody Miller, who will compete in swimming, track, and weightlifting events.

The venture has secured notable financial backing, with 1789 Capital—an investment firm associated with Donald Trump Jr.—and Peter Thiel leading a Series B funding round. While the company, trading as Enhanced Group, has experienced volatility since its recent public listing via a SPAC, proponents argue that the games represent a new era of athletic freedom and record-breaking potential. Organizers maintain that all substances used by athletes are FDA-approved and administered under strict medical supervision, though specific details regarding individual regimens remain private.

Beyond the spectacle of the competition, the organization has broader commercial ambitions. The company is positioning itself as a major player in the health and longevity market, with plans to retail a variety of supplements and performance-enhancing products. This includes a focus on the rapidly growing peptide market, with leadership expressing intentions to invest heavily in personalized enhancement solutions for health and recovery. The inaugural event will conclude with a performance by The Killers, marking a high-profile launch for a business model that seeks to challenge the status quo of professional sports.